All activities in the Netherlands have been terminated as of June 20th 2024
01-08-2023

PhD-defense Michiel Bannier

On June 22, 2023, Michiel Bannier, paediatric pulmonolgist at University Hospital Maastricht, the Netherlands, successfully defended his PhD-thesis ‘Non-Invasive Biomarkers in Paediatric Asthma’.

In chapter 5 of this thesis the feasibility of the aeoNose was investigated for the diagnostic of asthma and cystic fibrosis in children.

PhD thesis advisors: Prof. Dr. E. Dompeling, Dr. Q. Jöbsis, and Dr. A. Blanchet-Smolinska

PhD-defense Michiel Bannier

On June 22, 2023, Michiel Bannier, paediatric pulmonolgist at University Hospital Maastricht, the Netherlands, successfully defended his PhD-thesis.

Keynote at InterSystems Global Summit 2023

Prof Job van der Palen discussing the prospects of disease screening using an electronic nose.

PhD defense Yonne Peters (‘Cum laude’)

On May 11, 2023, Yonne Peters MD successfully defended her PhD-thesis ‘Early Detection of Esophageal Adenomacarcinoma and its Precursor Barrett’s Esophagus’ at Radboud University Nijmegen, the Netherlands.

The eNose Company will be present at HIMSS in Chicago, April 17-21, 2023

During the Healthcare Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition in Chicago, we will demonstrate the lung cancer application of the aeoNose using the IRIS4Health Intersystems platform for HIS-communication. You can find us at the Intersystems Booth#942 South Building.

PhD-defense Rens van de Goor

On March 3rd, Rens van de Goor, otolaryngologist at Bernhoven hospital, Uden, the Netherlands, successfully defended his PhD-thesis ‘Non-invasive diagnostic of head and neck cancer: feasibility of a portable electronic nose’.

Detecting lung cancer with electronic nose

Is it possible to detect lung cancer by smelling the air that someone exhales? Sharina Kort, lung specialist in training at MST, recently earned a PhD from the University of Twente (TechMed Centre) based on her research into that topic.

Results of study presented at ERS Barcelona

Sharina Kort MD, PhD presented the results of the study ‘Diagnosing non-small cell lung cancer by exhaled breath profiling using an electronic nose: A multicentre validation study’ on the ERS congress 2022 in Barcelona. Using the aeoNose, lung cancer patients could non-invasively be distinguished from non-lung cancer participants in a multinational validation setting. A paper on this study has recently been accepted by ‘Chest’.
Aeonose breath analysis on TB screening South Africa

Aeonose breath analysis on TB screening South Africa

This year, the Union World Conference on Lung Health was held in Hyderabad, India. At the TBScience pre-conference, an official event entirely devoted to basic and translational tuberculosis (TB) research, study results were presented on the Aeonose exhaled-breath tests in Cape Town.
Guts_eNose

Just published in ‘Gut’, results from a pilot study on Barrett’s oesophagus using the Aeonose

This year, the Union World Conference on Lung Health was held in Hyderabad, India. At the TBScience pre-conference, an official event entirely devoted to basic and translational tuberculosis (TB) research, study results were presented on the Aeonose exhaled-breath tests in Cape Town.
eNose apt

Multicenter study Colon rectal cancer and advanced adenomas

Timely detection of oesophageal adenocarcinoma (OAC) and even more so its precursor Barrett’s oesophagus (BO) could contribute to decrease OAC incidence and mortality. An accurate, minimally-invasive screening method for BO for widespread use is currently not available. In a proof-of-principle study in 402 patients, we developed and cross-validated a BO prediction model using volatile organic compounds (VOCs) analysis with an electronic nose device. This electronic nose was able to distinguish between patients with and without BO with good diagnostic accuracy (sensitivity 91% specificity 74%) and seemed to be independent of proton pump inhibitor use, the presence of hiatal hernia, and reflux. This technique may enable an efficient, well-tolerated, and sensitive and specific screening method to select high-risk individuals to undergo upper endoscopy.
© The eNose Company